Voxzogo (vosoritide) — United Healthcare
achondroplasia
Initial criteria
- Diagnosis of achondroplasia
- age < 18 years
- Patient has open epiphyses
Reauthorization criteria
- Documentation of positive clinical response to Voxzogo therapy
- Patient has open epiphyses
Approval duration
12 months